SPC Life Sciences is one of India’s leading manufacturers of advanced intermediates for certain key active pharmaceutical ingredients (APIs), including Pentoxifylline, AmiodaroneHCL, Cilostazol, Trazodone, Tramadol and Paroxetine. They are a research and development(R&D)driven chemical manufacturing company focused on chemistries involving long-chain multi-stage reactions. The advanced pharmaceutical intermediates (Pharma Intermediates) which are manufactured by them are used in certain growing therapeutic areas including cardiovascular, vasodilator (anti-platelet), anti-psychotic, and anti-depressants, with significant market share both in India and globally for some of the products. Equipped with a US FDA-approved facility for 6-Chloro-Hexane-2-One, they can develop Pharma Intermediates and work with pharmaceutical companies who seek US FDA-compliant manufacturing facilities as a part of their supply chain.
They invest in R&D activities to create a differentiating factor and sustainability is-à-vis their competitors. In addition to their manufacturing facilities at Ankleshwar and Dahej, they have a dedicated in-house R&D facility located at GIDC, Makarpura, Vadodara (R&D Facility). Our R&D Facility is spread over an aggregate built-up area of 1,390.46 sq. mts. and is equipped with an analytical development laboratory (ADL), infrastructure for developmental activities, freezing specifications, and developing the method of analysis for Key Starting Material (KSM), in-process intermediates, finished products, and other raw materials.
Objects of the Issue
- Re-payment/Prepayment of certain outstanding borrowings availed by our Company.
- Funding of capital expenditure requirements of our Company towards setting up Phase-2at our Dahej Facility to expand our product offerings of pharmaceutical intermediates.
- Funding our working capital requirements.
- General corporate purposes
SPC Life Sciences IPO Review (Apply or Not)
- To be updated soon
Brokerage Firm IPO Review
- Capital Market: To be updated soon
- Religare Broking: To be updated soon
- Hem Securities: To be updated soon
- Arihant Capital: To be updated soon
SPC Life Sciences IPO Date & Price Band Details
|IPO Size:||Approx ₹[.] Crores|
|Fresh Issue:||Approx ₹300 Crores|
|Offer for Sale:||Approx 8,938,870 Equity Shares|
|Face Value:||₹10 Per Equity Share|
|IPO Price Band:||₹[.] to ₹[.] Per Share|
|IPO Listing on:||BSE & NSE|
|DRHP Draft Prospectus:||Click Here|
|RHP Draft Prospectus:||Click Here|
|Anchor Investors List:||Click Here|
SPC Life Sciences IPO Market Lot
The SPC Life Sciences IPO minimum market lot is [.] shares with ₹[.] application amount. The retail investors can apply up-to 13 lots with [.] shares or ₹[.] amount.
SPC Life Sciences IPO Allotment & Listing Dates
The SPC Life Sciences IPO date is 2023 and the close date is October 2023. The SPC Life Sciences IPO allotment will be finalized on 2023 and the IPO listing on 2023.
|Price Band Announcement:||2023|
|Anchor Investors Allotment:||2023|
|IPO Open Date:||2023|
|IPO Close Date:||2023|
|Basis of Allotment:||2023|
|Credit to Demat Account:||2023|
|IPO Listing Date:||2023|
SPC Life Sciences IPO Form
How to apply for the SPC Life Sciences IPO? You can apply for SPC Life Sciences IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the SPC Life Sciences IPO in the Invest section. The other option is you can apply for SPC Life Sciences IPO via IPO forms downloaded via NSE and BSE. Check out the SPC Life Sciences forms – Click BSE Forms & NSE Forms blank IPO forms download, fill, and submit in your bank or with your broker.
SPC Life Sciences Company Financial Report
|₹ in Crores|
SPC Life Sciences IPO Valuation – FY2022
Check SPC Life Sciences IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
|Earning Per Share (EPS):||₹4.30 per Equity Share|
|Price/Earning P/E Ratio:||N/A|
|Return on Net Worth (RoNW):||28.00%|
|Net Asset Value (NAV):||₹61.48 per Equity Share|
- Aarti Industries
- Ami Organics
- Neogen Chemicals
- Aether Industries
- Anupam Rasayan
- Tatva Chintan
- Snehal Ravjibhai Patel
SPC Life Sciences IPO Registrar
Link Intime India Private Ltd
Phone: +91810 811 4949
Email: [email protected]
SPC Life Sciences IPO Allotment Status Check
Check SPC Life Sciences IPO allotment status on Linkintime website allotment URL. Click Here
SPC Life Sciences IPO Lead Managers aka Merchant Bankers
- Ambit Capital Private Limited
- HDFC Bank Limited
SPC Life Sciences Limited
284/1, 2 & 3, GIDC Estate,
Makarpura, Vadodara –390 010,
Phone: +91 2652658894;
E-mail: [email protected]
SPC Life Sciences IPO FAQs
What is SPC Life Sciences IPO?
When SPC Life Sciences IPO will open?
What is SPC Life Sciences IPO Investors Portion?
How to Apply the SPC Life Sciences IPO?
How to Apply the SPC Life Sciences IPO through Zerodha?
How to Apply the SPC Life Sciences IPO through Upstox?
How to Apply the SPC Life Sciences IPO through Paytm Money?
What is SPC Life Sciences IPO Size?
What is SPC Life Sciences IPO Price Band?
What is SPC Life Sciences IPO Minimum and Maximum Lot Size?
What is the SPC Life Sciences IPO Allotment Date?
What is the SPC Life Sciences IPO Listing Date?
Note: The SPC Life Sciences IPO price band and date are not officially announced yet. The IPO grey market premium (SPC Life Sciences IPO Premium) will be added to the IPO grey market page as it will start).
Follow IPO Watch for the Upcoming IPO news and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.